Author:
Lee Wonjong,Lee Jung Won,Kim Sungsun,Kim Jin Mook,Youn Dong-Hyun,Park Seong Hye,Kwon Chan Hyeok,Choi Sun-Ok
Funder
Ministry of Food and Drug Safety
National Institute of Food and Drug Safety Evaluation
Subject
Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry
Reference54 articles.
1. Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances-benzodiazepines diclazepam, flubromazepam, and pyrazolam-in the UK;Abouchedid;J. Med. Toxicol.,2018
2. A review of alprazolam use, misuse, and withdrawal;Ait-Daoud;J. Addict. Med.,2018
3. Adverse effects from counterfeit alprazolam tablets;Arens;JAMA Intern. Med.,2016
4. Benzodiazepine dependence: focus on withdrawal syndrome;Authier;Ann. Pharm. Fr.,2009
5. Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater;Bade;Anal. Methods,2020